American Gene Technologies Appoints Dr. Jeff Boyle as Chief Science Officer
|
Dr.
Boyle's biotech and intellectual property expertise strengthen the team as
the company proceeds to next phase of its HIV cure clinical trial. |
Stem cell HIV cure proves successful in oldest patient to date
He ceased antiretroviral therapy and was functionally cured. He became known as the Berlin Patient, and since that case there have been two more ... View article...